InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Silberstein Charles, Chief Financial Officer. Officer active across 1 company, notably Applied Therapeutics Inc.. Cumulatively, 8 disclosures have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €178k. Activity tracked since 8 June 2021. The latest transaction was filed on 7 January 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
47,900 shares0Common StockSEC:0001209191-22-002967:0
47,900 shares0Common StockSEC:0001209191-22-002971:0
47,900 shares0Common StockSEC:0001209191-22-002967
47,900 shares0Common StockSEC:0001209191-22-002971
47,900 shares0Common StockSEC:0001209191-21-070085
47,900 shares0Common StockSEC:0001209191-21-070085:0
5,047 shares@ US$21.4250.0% of flowCommon StockSEC:0001209191-21-039723:0
5,047 shares@ US$21.4250.0% of flowCommon StockSEC:0001209191-21-039723
8 of 8 declarations
About Silberstein Charles
Charles Silberstein serves as Chief Financial Officer at Applied Therapeutics Inc. In this role, he is responsible for the financial management of the organization, including overseeing budgets and investments. His expertise in finance enables him to ensure effective management of financial resources and contribute to the overall strategy of the company. He plays a crucial role in financial planning and strategic decision-making.
